| Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery M Segel, B Lash, J Song, A Ladha, CC Liu, X Jin, SL Mekhedov, ... Science 373 (6557), 882-889, 2021 | 330 | 2021 |
| Growth factor engineering strategies for regenerative medicine applications X Ren, M Zhao, B Lash, MM Martino, Z Julier Frontiers in bioengineering and biotechnology 7, 469, 2020 | 254 | 2020 |
| Highly parallel profiling of Cas9 variant specificity JL Schmid-Burgk, L Gao, D Li, Z Gardner, J Strecker, B Lash, F Zhang Molecular cell 78 (4), 794-800. e8, 2020 | 185 | 2020 |
| Programmable protein delivery with a bacterial contractile injection system J Kreitz, MJ Friedrich, A Guru, B Lash, M Saito, RK Macrae, F Zhang Nature 616 (7956), 357-364, 2023 | 159 | 2023 |
| Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist JL Tan, B Lash, R Karami, B Nayer, YZ Lu, C Piotto, Z Julier, MM Martino Communications biology 4 (1), 422, 2021 | 51 | 2021 |
| Modification of primary amines to higher order amines reduces in vivo hematological and immunotoxicity of cationic nanocarriers through TLR4 and complement pathways R Toy, P Pradhan, V Ramesh, NC Di Paolo, B Lash, J Liu, EL Blanchard, ... Biomaterials, 119512, 2019 | 28 | 2019 |
| Human paraneoplastic antigen Ma2 (PNMA2) forms icosahedral capsids that can be engineered for mRNA delivery V Madigan, Y Zhang, R Raghavan, ME Wilkinson, G Faure, E Puccio, ... Proceedings of the National Academy of Sciences 121 (11), e2307812120, 2024 | 15 | 2024 |
| Growth factor engineering strategies for regenerative medicine applications. Front Bioeng Biotechnol. 2020; 7: 469 X Ren, M Zhao, B Lash, MM Martino, Z Julier PUBMED, 2019 | 6 | 2019 |
| Growth factor engineering strategies for regenerative medicine applications, Front. Bioeng. Biotechnol. 7 (2020) X Ren, M Zhao, B Lash, MM Martino, Z Julier | 5 | 2019 |
| Engineered antigen presenting cells and uses thereof F Zhang, B Lash, D Strebinger US Patent 12,195,723, 2025 | 1 | 2025 |
| Rational engineering of minimally immunogenic nucleases for gene therapy R Raghavan, MJ Friedrich, I King, S Chau-Duy-Tam Vo, D Strebinger, ... Nature Communications 16 (1), 105, 2025 | | 2025 |
| Compositions and methods for delivering cargo to a target cell F Zhang, M Segel, B Lash US Patent App. 18/272,158, 2024 | | 2024 |
Mikaël M. MartinoEMBL Australia, Australian Regenerative Medicine Institute, Monash University, Osaka UniversityПотвърден имейл адрес: monash.edu